Co-Authors
This is a "connection" page, showing publications co-authored by Nicola Coppola and Ivan Gentile.
Connection Strength
3.229
-
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort. New Microbiol. 2019 Apr; 42(2):94-100.
Score: 0.820
-
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity-LINA cohort). Hepatol Int. 2019 Jan; 13(1):66-74.
Score: 0.798
-
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. Antivir Ther. 2017; 22(7):551-558.
Score: 0.703
-
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study. Front Aging Neurosci. 2021; 13:698184.
Score: 0.238
-
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study. Front Oncol. 2021; 11:662746.
Score: 0.236
-
Virological patterns of HCV patients with failure to interferon-free regimens. J Med Virol. 2018 05; 90(5):942-950.
Score: 0.188
-
Epidemiology and risk factors for hepatitis C virus genotypes in a high prevalence region in Italy. New Microbiol. 2018 Jan; 41(1):26-29.
Score: 0.185
-
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy. Life (Basel). 2021 Apr 16; 11(4).
Score: 0.059